Recent advancements in medical treatments and health research include new drug approvals, technology for diabetes management, and insights into long-standing health disparities.
Key Points
New data shows that cervical cancer screening rates are increasing overall, though persistent gaps remain for American Indian, Alaska Native, and Pacific Islander populations.
The FDA has granted approval for satralizumab to treat thyroid eye disease, marking continued expansion in the therapeutic options available for this condition.
The twiist Automated Insulin Delivery System has received FDA clearance, offering a new tool for adults managing type 2 diabetes with insulin therapy.
Brytly, an over-the-counter eye drop containing apraclonidine, has been approved as a new nonprescription treatment for eye redness in patients aged 12 and older.
Clinical research indicates that women with inflammatory bowel disease (IBD) have high success rates with fertility treatments, regardless of prior surgery or disease activity.
US retail markets have begun stocking sunscreen containing bemotrizinol, an ingredient noted for providing superior UVA protection compared to previous standards.
The All-Party Parliamentary Group (APPG) on Pharmacy is pressuring the government to release a delayed response regarding the potential for pharmacists to perform medicine substitutions.
A meta-analysis involving nearly 13,000 young people suggests that the impact of moderate-to-vigorous physical activity on certain cardiometabolic risk markers in youth may be weaker than previously assumed.